Park Financial Statements From 2010 to 2025
| BYAH Stock | 0.18 0.01 5.26% |
Check Park Ha financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Park Ha's main balance sheet or income statement drivers, such as , as well as many indicators such as . Park financial statements analysis is a perfect complement when working with Park Ha Valuation or Volatility modules.
Check out the analysis of Park Ha Correlation against competitors. Park Ha Biological Company Current Valuation Analysis
Park Ha's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Park Ha Current Valuation | 15.01 M |
Most of Park Ha's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Park Ha Biological is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Park Ha Biological has a Current Valuation of 15.01 M. This is 99.92% lower than that of the Consumer Defensive sector and 99.96% lower than that of the Household & Personal Products industry. The current valuation for all United States stocks is 99.91% higher than that of the company.
Park Ha Biological Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Park Ha's current stock value. Our valuation model uses many indicators to compare Park Ha value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Park Ha competition to find correlations between indicators driving Park Ha's intrinsic value. More Info.Park Ha Biological is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Park Ha's earnings, one of the primary drivers of an investment's value.About Park Ha Financial Statements
Investors use fundamental indicators, such as Park Ha's revenue or net income, to determine how well the company is positioned to perform in the future. Although Park Ha's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out the analysis of Park Ha Correlation against competitors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Household & Personal Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Park Ha. If investors know Park will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Park Ha listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Park Ha Biological is measured differently than its book value, which is the value of Park that is recorded on the company's balance sheet. Investors also form their own opinion of Park Ha's value that differs from its market value or its book value, called intrinsic value, which is Park Ha's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Park Ha's market value can be influenced by many factors that don't directly affect Park Ha's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Park Ha's value and its price as these two are different measures arrived at by different means. Investors typically determine if Park Ha is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Park Ha's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.